🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for CD7+ T-ALL/LBL

SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies NCT07153068Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: supCD7 CART cells To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT NCT07280494Phase 11 site📍 Beijing Peking University People's Hospital · Tests: CAR-T Therapy Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL NCT05626400NA1 site📍 Beijingcun Hebei Senlang Biotechnology Inc., Ltd. · Tests: Senl-T7 uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies NCT07109518Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: uCD7 CART CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study NCT06136364Phase 11 site📍 Shanghai Hebei Senlang Biotechnology Inc., Ltd. · Tests: CAR-T
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy